Oreofe O. Odejide

Oncology
450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: May 26, 2026

Top advances of the year: Palliative and supportive care in oncology.

Top advances of the year: Palliative and supportive care in oncology.

Journal: Cancer
Published: April 10, 2026

Insurance Type and Quality of End-of-Life Care in Adults < 65 Years with Hematologic Malignancies.

Insurance Type and Quality of End-of-Life Care in Adults < 65 Years with Hematologic Malignancies.

Journal: Journal of pain and symptom management
Published: March 24, 2026

A Feverish Pace.

A Feverish Pace.

Journal: The New England journal of medicine
Published: March 11, 2026

Patient-reported outcomes: a Polaris for POLARIX.

Patient-reported outcomes: a Polaris for POLARIX.

Journal: Blood
Published: January 15, 2026

Quality of life and symptoms in acute myeloid leukaemia with early palliative care: real-world observational study.

Quality of life and symptoms in acute myeloid leukaemia with early palliative care: real-world observational study.

Journal: BMJ supportive & palliative care
Published: November 25, 2025

Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers.

Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers.

Journal: JAMA network open
Published: November 05, 2025

End-of-Life Care for Older Adults With Blood Cancers With Medicare Advantage Versus Medicare Fee-For-Service Insurance.

End-of-Life Care for Older Adults With Blood Cancers With Medicare Advantage Versus Medicare Fee-For-Service Insurance.

Journal: JCO oncology practice
Published: September 15, 2025

Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Journal: Cancer
Published: September 13, 2025

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.

Journal: Blood neoplasia
Published: June 24, 2025

Evaluating Vulnerable Elders Survey-13 and FIL Geriatric Assessment in Older Adults With Aggressive Lymphomas.

Evaluating Vulnerable Elders Survey-13 and FIL Geriatric Assessment in Older Adults With Aggressive Lymphomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 03, 2025

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

Journal: Blood advances
Published: January 24, 2025
Showing 1-12 of 78

Last Updated: 09/26/2026